content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
  <submissionType>144</submissionType>
  <filerInfo>
  <filer>
  <filerCredentials>
  <cik>0001997710</cik>
  <ccc>XXXXXXXX</ccc>
  </filerCredentials>
  </filer>
  <liveTestFlag>LIVE</liveTestFlag>
  </filerInfo>
  </headerData>
  <formData>
  <issuerInfo>
  <issuerCik>0001501796</issuerCik>
  <issuerName>Aura Biosciences, Inc.</issuerName>
  <secFileNumber>001-40971</secFileNumber>
  <issuerAddress>
  <street1 xmlns="http://www.sec.gov/edgar/common">80 Guest Street</street1>
  <city xmlns="http://www.sec.gov/edgar/common">Boston</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">MA</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">02135</zipCode>
  </issuerAddress>
  <issuerContactPhone>617-500-8864</issuerContactPhone>
  <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Janet Jill Hopkins</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
  <relationshipsToIssuer>
  <relationshipToIssuer>Officer</relationshipToIssuer>
  </relationshipsToIssuer>
  </issuerInfo>
  <securitiesInformation>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <brokerOrMarketmakerDetails>
  <name>Morgan Stanley Smith Barney LLC Drive</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">200 West Civic Center</street1>
  <city xmlns="http://www.sec.gov/edgar/common">Sandy</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">UT</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">84070</zipCode>
  </address>
  </brokerOrMarketmakerDetails>
  <noOfUnitsSold>11822</noOfUnitsSold>
  <aggregateMarketValue>110663.24</aggregateMarketValue>
  <noOfUnitsOutstanding>49951466</noOfUnitsOutstanding>
  <approxSaleDate>11/18/2024</approxSaleDate>
  <securitiesExchangeName>Nasdaq</securitiesExchangeName>
  </securitiesInformation>
  <securitiesToBeSold>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <acquiredDate>11/01/2023</acquiredDate>
  <natureOfAcquisitionTransaction>Restricted Stock unit award granted pursuant to the Issuer's 2021 Stock Option and Incentive Plan, subject to vesting requirements.</natureOfAcquisitionTransaction>
  <nameOfPersonfromWhomAcquired>Aura Biosciences, Inc.</nameOfPersonfromWhomAcquired>
  <isGiftTransaction>N</isGiftTransaction>
  <amountOfSecuritiesAcquired>33750</amountOfSecuritiesAcquired>
  <paymentDate>11/01/2023</paymentDate>
  <natureOfPayment>N/A</natureOfPayment>
  </securitiesToBeSold>
  <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
  <remarks>The sales reported on this Form 144 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.</remarks>
  <noticeSignature>
  <noticeDate>11/18/2024</noticeDate>
  <signature>/s/ Amy Elazzouzi, as Attorney-in-Fact</signature>
  </noticeSignature>
  </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3109}]
text: 144
  0001997710
  XXXXXXXX
  LIVE
  0001501796
  Aura Biosciences, Inc.
  001-40971
  80 Guest Street
  Boston
  MA
  02135
  617-500-8864
  Janet Jill Hopkins
  Officer
  Common Stock
  Morgan Stanley Smith Barney LLC Drive
  200 West Civic Center
  Sandy
  UT
  84070
  11822
  110663.24
  49951466
  11/18/2024
  Nasdaq
  Common Stock
  11/01/2023
  Restricted Stock unit award granted pursuant to the Issuer's 2021 Stock Option and Incentive Plan, subject to vesting requirements.
  Aura Biosciences, Inc.
  N
  33750
  11/01/2023
  N/A
  Y
  The sales reported on this Form 144 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
  11/18/2024
  /s/ Amy Elazzouzi, as Attorney-in-Fact